JP2021521412A5 - - Google Patents
Info
- Publication number
- JP2021521412A5 JP2021521412A5 JP2020544212A JP2020544212A JP2021521412A5 JP 2021521412 A5 JP2021521412 A5 JP 2021521412A5 JP 2020544212 A JP2020544212 A JP 2020544212A JP 2020544212 A JP2020544212 A JP 2020544212A JP 2021521412 A5 JP2021521412 A5 JP 2021521412A5
- Authority
- JP
- Japan
- Prior art keywords
- proteins
- stationary phase
- phase material
- data
- purity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862633584P | 2018-02-21 | 2018-02-21 | |
| US62/633,584 | 2018-02-21 | ||
| PCT/US2019/019050 WO2019165148A1 (en) | 2018-02-21 | 2019-02-21 | Determining conditions for purification of proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521412A JP2021521412A (ja) | 2021-08-26 |
| JP2021521412A5 true JP2021521412A5 (enExample) | 2022-03-02 |
| JP7332610B2 JP7332610B2 (ja) | 2023-08-23 |
Family
ID=65763767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020544212A Active JP7332610B2 (ja) | 2018-02-21 | 2019-02-21 | タンパク質の精製条件の決定 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200408728A1 (enExample) |
| EP (2) | EP3755447B1 (enExample) |
| JP (1) | JP7332610B2 (enExample) |
| CA (1) | CA3091905C (enExample) |
| ES (1) | ES2978413T3 (enExample) |
| WO (1) | WO2019165148A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY204234A (en) | 2018-08-27 | 2024-08-16 | Regeneron Pharma | Use of raman spectroscopy in downstream purification |
| WO2021216635A1 (en) * | 2020-04-23 | 2021-10-28 | Amgen Inc. | Selecting chromatography parameters for manufacturing therapeutic proteins |
| WO2022060535A1 (en) * | 2020-09-21 | 2022-03-24 | Bayer Healthcare Llc | Pathogen clearance system and method |
| EP4780828A2 (en) * | 2023-09-18 | 2026-07-29 | Regeneron Pharmaceuticals, Inc. | Methods and systems for developing chromatography protocols |
| CN121075496B (zh) * | 2025-11-05 | 2026-03-27 | 鲁东大学 | 一种基于特征工程与集成学习的蛋白质盐敏感性预测方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020010566A1 (en) * | 2000-04-11 | 2002-01-24 | Chester Thomas Lee | Methods for modeling, predicting, and optimizing high performance liquid chromatography parameters |
| US20040034477A1 (en) * | 2002-08-19 | 2004-02-19 | Mcbrien Michael | Methods for modeling chromatographic variables |
| EP1539321A1 (de) * | 2002-09-19 | 2005-06-15 | MERCK PATENT GmbH | Verfahren zum auffinden geeigneter chromatographiebedingungen zur trennung biologischer moleküle |
| DE102006027496B3 (de) * | 2006-06-14 | 2008-01-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Optimierung chromatographischer Reinigungsverfahren für Biomoleküle |
| JP6656710B2 (ja) * | 2014-11-12 | 2020-03-04 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 液体クロマトグラフィープロトコルにおける実験パラメータの影響を決定するための方法及びシステム |
| GB2539420B (en) * | 2015-06-16 | 2021-01-13 | Cytiva Sweden Ab | Determination of chromatography conditions |
-
2019
- 2019-02-21 CA CA3091905A patent/CA3091905C/en active Active
- 2019-02-21 JP JP2020544212A patent/JP7332610B2/ja active Active
- 2019-02-21 EP EP19710843.4A patent/EP3755447B1/en active Active
- 2019-02-21 EP EP24161128.4A patent/EP4372376B1/en active Active
- 2019-02-21 WO PCT/US2019/019050 patent/WO2019165148A1/en not_active Ceased
- 2019-02-21 US US16/969,522 patent/US20200408728A1/en active Pending
- 2019-02-21 ES ES19710843T patent/ES2978413T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Timms et al. | Difference gel electrophoresis | |
| Dowling et al. | Fiber-type shifting in sarcopenia of old age: proteomic profiling of the contractile apparatus of skeletal muscles | |
| Qian et al. | Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag Approach* S | |
| Lame et al. | Quantitation of amyloid beta peptides Aβ1–38, Aβ1–40, and Aβ1–42 in human cerebrospinal fluid by ultra-performance liquid chromatography–tandem mass spectrometry | |
| Jing et al. | Methods for measuring aptamer-protein equilibria: a review | |
| Millioni et al. | High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity | |
| JP2020514746A5 (enExample) | ||
| Østergaard et al. | Bioanalytical interaction studies executed by preincubation affinity capillary electrophoresis | |
| Dowling et al. | Proteomic profiling of carbonic anhydrase CA3 in skeletal muscle | |
| JP7332610B2 (ja) | タンパク質の精製条件の決定 | |
| Kim et al. | Human blood plasma preparation for two-dimensional gel electrophoresis | |
| JP2012108118A (ja) | ヘモグロビンＡ１ｃ測定における校正方法 | |
| Li et al. | Screening and identification of specific aptamers for shellfish allergen tropomyosin with capillary electrophoresis-SELEX | |
| Herosimczyk et al. | Plasma proteome analysis: 2D geld and chips | |
| US10376813B2 (en) | Determination of chromatography conditions | |
| Diez et al. | 2-D fluorescence difference gel electrophoresis (DIGE) in neuroproteomics | |
| Wiederkehr et al. | Two-dimensional gel electrophoresis of cerebrospinal fluid proteins from patients with various neurological diseases. | |
| Salmanowicz et al. | Charge-based characterisation of high-molecular-weight glutenin subunits from common wheat by capillary isoelectric focusing | |
| Staunton et al. | Proteomic analysis of muscle affected by motor neuron degeneration: the wobbler mouse model of amyotrophic lateral sclerosis | |
| Ogata et al. | Retention order reversal of phosphorylated and unphosphorylated peptides in reversed-phase LC/MS | |
| WO2017032848A1 (en) | Method for determining affinity of a biomolecule | |
| Ohlendieck | Comparative 3-Sample 2D-DIGE Analysis of Skeletal Muscles | |
| CN105334329A (zh) | 钙蛋白酶磷酸化水平的测定方法 | |
| JP2017534867A (ja) | 平衡シフト法による結合定数の決定 | |
| Hansson et al. | Sample preparation for endopeptidomic analysis in human cerebrospinal fluid |